1.Research Progress of HBeAg-negative Chronic Hepatitis BHBeAg阴性慢性乙型肝炎研究进展 2.To investigate the effect ofα-interferon (INF-α)therapy for HBeAg-negative chronic hepatitis B (CHB).了解干扰素治疗HBeAg阴性慢性乙型肝炎的疗效。 3.Objective To probe into the clinical characteristic of the HBe...
参考文献: van Bömmel F, Stein K, Heyne R, et al. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B. J Hepatol. 2023;78(5):926-936.
近年来慢性乙型肝炎中乙型肝炎 e 抗原(hepatitis B e antigen,HBeAg)阴性慢性HBV感染者(HBeAg-negative chronic HBV infection,ENCI)数量越来越多[3],患者病情进展隐匿,丙氨酸转氨酶(alanine transaminase,ALT)持续正常的HBeAg阴性患者仍有8%...
[5]Fasano M, Ciarallo M, Niro G, et al. HBsAg loss is enough to discontinue long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B patients in real practice[J]. Dig Liver Dis. 2015. 47(Suppl...
HBsAg, HBcrAg, and HBV RNA in outcomes and after NA discontinuation in HBeAg negative patients with chronic hepatits B: results from the Toronto STOP Study. EASL2021. Abstracts(PO-2269). [2] Johannessen A, Reikvam DH, Aleman S, et al. One-year safety results of the Nuc-Stop Study, ...
The preliminary observation of adefovir treatment for 46 patients with HBeAg negative chronic hepatitis B; 阿德福韦治疗HBeAg阴性慢性乙型肝炎患者的初步观察 2. Study on relationgship between viral dynamics change and curative effect in patients with HBeAg negative chronic hepatitis B treated with adefovir...
参考文献：Jing Zhou, Fa-Da Wang, Lan-Qing Li, Yu-Jin Li, Shi-Yan Wang, En-Qiang Chen. Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity. J Clin Transl Hepatol 2023. doi: 10.14218/JCTH....
[1] Alexopoulou A, Karayiannis P. HBeAg negative variants and their role in the natural history of chronic hepatitis B virus infection.World J Gastroenterol2014; 20(24): 7644-7652 [2] 陈华仙 韦嘉.HBeAg 阴性慢性乙型肝炎的诊治进展[J].临床肝胆病杂, 2020, 36(7). ...
1) HBeAg-negative e抗原阴性 2) HBeAg e抗原 1. Study relation between the level of serum HBV-DNA and PreS1 andHBeAg; 乙型肝炎患者血清HBV-DNA载量与前S1抗原和e抗原关系探讨 2. Preparation of Anti-HBe Monoclonal Antibody fromHBeAgPositive Human Serum and its Identification; ...
For HBeAg-negative patients, tenofovir followed by lamivudine has an ICER of 9811 pounds per QALY gained, compared with best supportive care.5个回答 对于HBeAg阴性患者,拉米夫定替诺福韦有9811磅每QALY的上涨ICER,与最佳支持治疗相比。2013-05-23 12:21:38...